ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

September 28, 1979

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

November 15, 1991

HIPAA Interpretations Vary, Delay Research, ASCO Study Finds

July 31, 2009

Breaking With Tradition, NIH Director Heads Obama’s Search for NCI Director.

February 12, 2010

Stronger Federal Role Needed To Improve Palliative Care.

June 22, 2001

NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others

October 18, 1996